MedTrace Logo

Multicenter Epidemiologic Study of Severe Community Acquired Pneumonia in China

NCT03728816 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2018-11-02

No results posted yet for this study

Summary

This study is aimed to understand the clinical characteristics, etiology and resistance phenotype of major pathogens of SCAP in China through multicenter and prospective investigation. Thus to provide epidemiological basis for improving the SCAP diagnosis and treatment protocol suitable for China.

Conditions

  • Community-acquired Pneumonia

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Principal Investigators

  • Jieming QU, h.D.,M.D. · Ruijin Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-10
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03728816 on ClinicalTrials.gov